查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1565074

胡佛针的全球市场

Huber Needles
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球胡佛针市场预计将达到 9,430 万美元

胡佛针的全球市场预计 2023 年为 6,780 万美元，预计到 2030 年将达到 9,430 万美元，2023-2030 年分析期间复合年增长率为 4.8%。静脉癌症治疗应用是本报告分析的细分市场之一，预计复合年增长率为 5.4%，到分析期结束时将达到 4,570 万美元。分析期间，输血应用领域的复合年增长率预计为 4.3%。

美国市场预估为1,840万美元，中国预期复合年增长率为4.5%

预计 2023 年美国胡佛针市场规模将达 1,840 万美元。中国作为世界第二大经济体，预计2030年市场规模将达到1,480万美元，2023-2030年分析期间复合年增长率为4.5%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.7% 和 3.7%。在欧洲，德国的复合年增长率预计为 3.9%。

全球胡佛针市场—主要趋势与驱动因素总结

胡佛针是安全有效长期用药的关键吗？

胡佛针已成为现代医疗保健的重要工具，但为什么它们对于安全有效的长期给药至关重要？胡佛针是一种没有取芯的专用针，设计用于进入植入的血管通路装置，例如需要长期静脉治疗的患者使用的端口。这些针头广泛用于接受化疗、输血和长期静脉治疗的患者，提供了一种可靠、安全的给药方式，无需反覆刺穿静脉。

胡佛针的吸引力在于其独特的设计，可最大程度地减少组织损伤并降低取芯风险（小块组织被切断并引入血液中）。这使其成为需要频繁或长期访问中心静脉港的患者的理想选择。胡佛针既舒适又安全，确保治疗有效进行，没有不必要的疼痛或併发症。随着医疗保健提供者寻求改善慢性病护理环境中的患者照护，胡佛针对于保持血管通路装置的完整性、同时最大限度地减少不适和风险至关重要。

科技如何改进 Huber 针？

技术进步显着提高了 Huber 针的安全性、功能性和易用性，使其更有效、更可靠地进行长期给药。最重要的进步之一是引入了安全设计的 Huber 针。这些针头配备了安全机制，可保护医护人员免受意外针刺，避免接触血源性病原体。许多 Huber 针头均标配安全功能，例如自动针头回缩和防护，以降低受伤风险并促进临床环境中更安全的工作环境。

材料和涂层的改进也提高了胡佛针的性能。现代胡佛针通常由先进的不銹钢製成，具有耐用性、灵活性和生物相容性。有些针头具有涂层，可以减少插入过程中的摩擦，使过程更顺畅，患者更舒适。这种涂层还有助于最大限度地减少对周围组织的创伤，并减少端口部位刺激和感染的可能性。

除了安全性和材料改进之外，Huber 针的设计也经过改进，以提高准确性和患者舒适度。许多较新的型号具有倾斜或符合人体工学的设计，以便于医疗保健专业人员操作和精确定位。这会减少插入过程中的併发症，并使患者更稳定地进入连接埠。此外，人体工学设计提高了护理人员和医生的整体可用性，因为他们经常需要在复杂的高压环境中处理这些针头。

流量控制胡佛针是另一个重要的进步。这些针灸针旨在改善药物通过针头的流动并更有效地确保剂量。对于化疗和输血，确保准确和稳定的流速对于治疗效果和病人安全至关重要。流量控制的 Huber 针减少了阻塞和不一致输送的机会，这可能会影响患者照护。

更细规格的 Huber 针的出现也扩大了 Huber 针的用途。细针在插入过程中可减少疼痛和组织损伤，对于需要频繁治疗的患者来说特别舒适。这些细针可最大程度地减少不适，同时保持有效的端口通路，使它们对儿科患者以及皮肤和组织敏感的患者特别有益。

为什么胡佛针对长期患者照护和药物输送至关重要？

Huber 针对长期患者照护和药物传递至关重要，因为它们为需要频繁静脉注射治疗的患者提供了一种安全、可靠且微创的进入血管端口的方法。许多接受化疗、慢性疼痛治疗​​和长期静脉注射治疗的患者受益于植入式端口，这些端口允许医疗保健专业人员将治疗直接注入血液中。胡佛针经过专门设计，可以在不损坏这些端口的情况下进入这些端口，从而使它们能够长时间保持功能。

胡佛针的主要优点之一是其无穿刺设计。 Huber 针在刺穿血管端口时不会解剖组织，从而降低了取芯和血流污染的风险。此功能对于保持端口完整性和防止感染和阻塞等併发症至关重要。确保端口的使用寿命和安全对于依赖端口进行救生治疗的患者至关重要，而 Huber 针在这过程中发挥关键作用。

Huber 针还可以透过减少重复针刺带来的疼痛和创伤来提高患者的舒适度。当多次使用传统针头进入端口时，会造成严重的不适和组织损伤。然而，Huber 针的设计最大限度地减少了组织创伤，使其成为长期治疗方法的首选。这对于需要连续数月或数年每週或每天访问端口的化疗患者尤其重要。使用胡佛针可以最大程度地减少疼痛、降低感染风险并改善患者的整体健康。

胡佛针重要的另一个原因是安全和受控的药物输送。对于化疗等需要精确剂量和时间安排的治疗，Huber 针可确保药物直接进入血液，而不会出现併发症。其可靠性对于降低药物洩漏或阻塞的风险至关重要，药物洩漏或阻塞会影响治疗效果。此外，它与各种输注疗法和输注速率相容，使其可用于从化疗到肠外营养的各种临床应用。

胡佛针对于保护医护人员也至关重要。胡佛针整合了安全设计功能，有助于防止意外针刺，从而传播爱滋病毒和肝炎等血感染疾病。在医护人员每天处理大量针头的繁忙临床环境中，胡佛针的​​安全功能提供了额外的保护层，确保在不让工作人员面临风险的情况下进行治疗。

推动胡佛针市场成长的因素有哪些？

胡佛针市场成长的因素有很多，包括慢性病盛行率的上升、化疗和其他长期治疗需求的增加以及针安全技术的进步。主要驱动因素之一是需要长期静脉治疗的患者数量不断增加，特别是正在接受癌症治疗的患者。随着全球癌症发生率的上升，越来越多的患者正在接受化疗，通常使用血管通路装置，例如端口。对安全可靠地存取这些装置的需求导致对 Huber 针的需求增加，Huber 针为连接埠存取提供了一种非刺穿、舒适且有效的解决方案。

越来越多地使用植入式输液港来治疗各种慢性疾病也是推动市场成长的关键因素。输液港不仅用于治疗肿瘤，还用于治疗自体免疫疾病、慢性疼痛以及需要透过肠外营养进行长期营养支持的患者。随着此类治疗变得越来越普遍，对能够安全进入输液港且无併发症的 Huber 针的需求将继续增长。

针头安全技术的进步也推动了市场的扩张。对针刺伤和相关健康风险的认识不断提高，人们越来越重视开发和采用安全设计的 Huber 针。这些针头降低了意外接触血源性病原体的风险，保护了医护人员和病人。对改善医疗机构职业安全的关注导致安全针头的广泛采用，促进了胡佛针头市场的整体成长。

人口老化也是市场成长的一个主要因素。随着世界人口老化，癌症、心血管疾病、糖尿病等慢性病患者数量不断增加。其中许多患者需要长期静脉注射治疗或定期血管端口通路，这推动了对胡佛针的需求。此外，老年患者的静脉更加脆弱，使得 Huber 针成为最大程度地减少组织损伤并确保治疗期间舒适的首选。

胡佛针设计和材料的技术进步也促进了市场的成长。使胡佛针更加准确、舒适和安全的创新使其对医疗保健提供者更具吸引力。更细的针头、人体工学设计和先进的安全功能的开发提高了患者和医疗保健专业人员的使用便利性。随着这些创新的进步，胡佛针的​​市场预计将进一步扩大，医疗保健提供者寻求最好的工具来提供长期、优质的照护。

对以病人为中心的照护的日益关注也是影响胡佛针市场成长的因素。随着医疗保健提供者越来越注重改善接受长期治疗的患者的生活质量，对能够最大限度地减少不适和併发症的医疗设备的需求不断增长。胡佛针透过专注于缓解疼痛和保护血管端口的设计来满足这些目标，使其成为患者照护策略的重要组成部分。

由于慢性病的增加、安全技术的进步以及对长期治疗解决方案的需求不断增长，胡佛针市场预计将持续成长。随着医疗保健提供者优先考虑安全、效率和患者舒适度，胡佛针将继续成为跨各种医学学科安全有效地提供关键治疗的重要工具。

调查企业范例（共41例）

  • AngioDynamics, Inc.
  • B. Braun Medical, Inc.
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • EXELINT International Co.
  • Nipro Medical Corporation
  • Smiths Medical
  • Thibaut SAS
  • Vygon SA

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP12448

Global Huber Needles Market to Reach US$94.3 Million by 2030

The global market for Huber Needles estimated at US$67.8 Million in the year 2023, is expected to reach US$94.3 Million by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. IV Cancer Treatment Application, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$45.7 Million by the end of the analysis period. Growth in the Blood Transfusions Application segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$18.4 Million While China is Forecast to Grow at 4.5% CAGR

The Huber Needles market in the U.S. is estimated at US$18.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$14.8 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Huber Needles Market - Key Trends and Drivers Summarized

Are Huber Needles the Key to Safe and Efficient Long-Term Medication Delivery?

Huber needles have become an indispensable tool in modern healthcare, but why are they so essential for the safe and efficient delivery of medications over extended periods? A Huber needle is a specialized, non-coring needle designed to access implanted vascular access devices, such as ports used in patients requiring long-term intravenous (IV) treatments. These needles are widely used in patients undergoing chemotherapy, blood transfusions, or long-term IV therapy, as they provide a reliable and safe way to administer medication without repeatedly puncturing veins.

The appeal of Huber needles lies in their unique design, which minimizes tissue damage and reduces the risk of coring (where a small piece of tissue is cut and introduced into the bloodstream). This makes them ideal for patients who need frequent or long-term access to central venous ports. Huber needles offer both comfort and safety, ensuring that treatments are delivered effectively without causing unnecessary pain or complications. As healthcare providers seek to enhance patient care in chronic treatment settings, Huber needles are critical for maintaining the integrity of vascular access devices while minimizing discomfort and risk.

How Has Technology Advanced Huber Needles?

Technological advancements have significantly improved the safety, functionality, and ease of use of Huber needles, making them more efficient and reliable for long-term medication delivery. One of the most important developments is the introduction of safety-engineered Huber needles. These needles are equipped with safety mechanisms that protect healthcare workers from accidental needlestick injuries, which can expose them to bloodborne pathogens. Safety features like automatic needle retraction or shielding have become standard in many Huber needles, reducing the risk of injury and promoting a safer work environment in clinical settings.

Improved materials and coatings have also enhanced the performance of Huber needles. Modern Huber needles are often made with advanced stainless steel, which provides durability, flexibility, and biocompatibility. Some needles feature coatings that reduce friction during insertion, making the process smoother and more comfortable for patients. These coatings can also help minimize trauma to the surrounding tissue, reducing irritation and the potential for infection around the port site.

In addition to safety and material improvements, the design of Huber needles has become more refined, with innovations that enhance precision and patient comfort. Many newer models have angled or ergonomic designs that make them easier for healthcare providers to handle and position accurately. This leads to fewer complications during insertion and more consistent access to the patient’s port. Additionally, the ergonomic design improves the overall user experience for nurses and doctors, who must often handle these needles in complex, high-pressure environments.

Flow-controlled Huber needles represent another significant advancement. These needles are designed to improve the flow of medication or fluids through the needle, ensuring that dosages are administered more efficiently. In the context of chemotherapy or blood transfusions, ensuring accurate and steady flow rates is crucial for both the efficacy of treatment and patient safety. Flow-controlled Huber needles help reduce the likelihood of blockages or inconsistent delivery, which can compromise patient care.

The availability of smaller gauge Huber needles has also expanded the applications of these devices. Smaller gauge needles cause less pain and tissue damage upon insertion, making them more comfortable for patients, especially those requiring frequent treatments. These finer needles are particularly beneficial for pediatric patients or individuals with more sensitive skin or tissue, as they minimize discomfort while maintaining effective port access.

Why Are Huber Needles Critical for Long-Term Patient Care and Medication Delivery?

Huber needles are critical for long-term patient care and medication delivery because they provide a safe, reliable, and less invasive method for accessing vascular ports in patients who require frequent IV treatments. Many patients undergoing chemotherapy, chronic pain management, or long-term IV therapy benefit from implanted ports, which allow healthcare providers to administer treatments directly into the bloodstream. Huber needles are specially designed to access these ports without damaging them, ensuring that the port remains functional over extended periods.

One of the primary advantages of Huber needles is their non-coring design. When a Huber needle punctures a vascular port, it does not remove tissue, thereby reducing the risk of coring and contamination of the bloodstream. This feature is essential for maintaining the integrity of the port and preventing complications such as infections or blockages. For patients who depend on their ports for life-saving treatments, ensuring the longevity and safety of the port is crucial, and Huber needles play a vital role in this process.

Huber needles also improve patient comfort by reducing the pain and trauma associated with repeated needle insertions. Traditional needles can cause significant discomfort and tissue damage when used to access a port multiple times. However, the design of Huber needles minimizes tissue trauma, making them a preferred option for long-term treatment regimens. This is especially important in chemotherapy patients, who may need weekly or even daily access to their ports over the course of several months or years. The use of Huber needles helps minimize pain, reduces the risk of infection, and promotes better overall patient well-being.

The safe and controlled delivery of medications is another reason why Huber needles are so important. In treatments such as chemotherapy, where precise dosing and timing are essential, Huber needles ensure that the medication is delivered directly into the bloodstream without complications. Their reliability is critical in reducing the risk of drug leaks, blockages, or other issues that could compromise the efficacy of treatment. Additionally, their compatibility with a wide range of IV therapies and infusion rates makes them versatile for various clinical applications, from chemotherapy to parenteral nutrition.

Huber needles are also vital for the protection of healthcare workers. With the integration of safety-engineered features, Huber needles help prevent accidental needlestick injuries, which can transmit bloodborne diseases such as HIV or hepatitis. In busy clinical environments where healthcare workers may handle multiple needles daily, the safety features of Huber needles provide an added layer of protection, ensuring that treatments are administered without putting staff at risk.

What Factors Are Driving the Growth of the Huber Needles Market?

Several factors are driving the growth of the Huber needles market, including the rising prevalence of chronic diseases, increasing demand for chemotherapy and other long-term treatments, and advancements in needle safety technology. One of the primary drivers is the growing number of patients requiring long-term intravenous therapies, particularly those undergoing cancer treatment. As the global incidence of cancer rises, more patients are being treated with chemotherapy, often through vascular access devices like ports. The need for safe and reliable access to these devices is contributing to the increased demand for Huber needles, which offer a non-coring, comfortable, and effective solution for port access.

The expanding use of implanted ports for a variety of chronic conditions is another key factor fueling market growth. Ports are not only used in oncology but also in patients with autoimmune diseases, chronic pain conditions, or those needing long-term nutrition support via parenteral nutrition. As these treatments become more common, the demand for Huber needles that can safely access these ports without causing complications will continue to grow.

Advancements in needle safety technology are also driving market expansion. With increased awareness of needlestick injuries and the associated health risks, there is a growing emphasis on the development and adoption of safety-engineered Huber needles. These needles reduce the risk of accidental exposure to bloodborne pathogens, protecting both healthcare workers and patients. The focus on improving occupational safety in healthcare settings has led to wider adoption of safety needles, contributing to the overall growth of the Huber needles market.

The aging population is another significant driver of market growth. As the global population ages, the number of individuals living with chronic diseases such as cancer, cardiovascular conditions, and diabetes is increasing. Many of these patients require long-term IV therapies or regular access to vascular ports, driving the demand for Huber needles. Additionally, elderly patients may have more delicate veins, making Huber needles a preferred option for minimizing tissue damage and ensuring comfort during treatments.

Technological advancements in the design and materials used in Huber needles have also contributed to market growth. Innovations that enhance the precision, comfort, and safety of Huber needles have made them more attractive to healthcare providers. The development of smaller gauge needles, more ergonomic designs, and advanced safety features has improved the user experience for both patients and healthcare workers. As these innovations continue, the market for Huber needles is expected to expand further, with healthcare providers seeking the best tools to deliver long-term, high-quality care.

The increasing focus on patient-centered care is another factor influencing the growth of the Huber needles market. As healthcare providers place greater emphasis on improving the quality of life for patients undergoing long-term treatments, there is a growing demand for medical devices that minimize discomfort and complications. Huber needles, with their design focused on reducing pain and protecting vascular ports, align with these goals, making them a critical component in patient care strategies.

With the rising prevalence of chronic diseases, advancements in safety technology, and the growing need for long-term treatment solutions, the Huber needles market is poised for continued growth. As healthcare providers prioritize safety, efficiency, and patient comfort, Huber needles will remain an essential tool in ensuring the safe and effective delivery of critical therapies across various medical disciplines.

Select Competitors (Total 41 Featured) -

  • AngioDynamics, Inc.
  • B. Braun Medical, Inc.
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • EXELINT International Co.
  • Nipro Medical Corporation
  • Smiths Medical
  • Thibaut SAS
  • Vygon SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Huber Needles - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Oncology and Chronic Disease Management Drives Growth in Huber Needles Market
    • Expansion of Intravenous Drug Administration and Parenteral Nutrition Spurs Adoption of Huber Needles
    • Growth in Use of Huber Needles for Long-term Vascular Access Expands Addressable Market
    • Role of Huber Needles in Enhancing Patient Comfort and Reducing Needle-stick Injuries Strengthens Business Case for Adoption
    • Growth in Use of Huber Needles in Chemotherapy and Blood Transfusions Expands Market Opportunities
    • Role of Huber Needles in Supporting Home-based Infusion Therapy and Parenteral Nutrition Expands Addressable Market
    • Growth in Use of Huber Needles in Central Venous Catheterization and Port Access Strengthens Market Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Huber Needles Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Huber Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Huber Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Huber Needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for IV Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for IV Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for IV Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Blood Transfusions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Blood Transfusions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Blood Transfusions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Dialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Lap-Band Adjustments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Lap-Band Adjustments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Lap-Band Adjustments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Curved Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Curved Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Curved Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Straight by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Straight by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Straight by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • JAPAN
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • CHINA
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • EUROPE
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Huber Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Huber Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Huber Needles by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • FRANCE
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • GERMANY
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030

IV. COMPETITION